The Hospital And Nursing Home Probiotics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for hospital and nursing home probiotics has seen swift expansion recently. The market size increased from $1.51 billion in 2024 and is projected to reach $1.69 billion in 2025, with a compound annual growth rate (CAGR) of 11.81%.
The Hospital And Nursing Home Probiotics Global Market is projected to grow to $2.61 billion by 2029, with a compound annual growth rate (CAGR) of 11.44%.
Download Your Free Sample of the 2025 Hospital And Nursing Home Probiotics Market Report and Uncover Key Trends Now!The key drivers in the hospital and nursing home probiotics market are:
•Rising adoption and awareness of probiotics benefits
•Increased demand for digestive health solutions
•Increased focus on preventing hospital-acquired infections (HAIs)
•Growing investment in probiotic-based medical nutrition
The hospital and nursing home probiotics market covered in this report is segmented –
1) By Indication: Antibiotic-Associated Diarrhea, Irritable Bowel Syndrome, Clostridium difficile Infection, Inflammatory Bowel Disease, General Gut Health
2) By Formulation Type: Capsules, Powder, Liquid, Soft Chew, Probiotic Yogurt
3) By Patient Group: Infants, Adults, Elderly, Immunocompromised Patients, Patients With Gastrointestinal Disorders
4) By Distribution Channel: Hospitals, Nursing Homes, Pharmacies, Online Retail, Healthcare Facilities
5) By Application: Gut Health, Immunity, Wellness, Other Applications
Subsegments:
1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD, Treatment of AAD
2) By Irritable Bowel Syndrome (IBS):IBS With Diarrhea (IBS-D), IBS With Constipation (IBS-C), Mixed IBS (IBS-M)
3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence, Treatment Of CDI
4) By Inflammatory Bowel Disease (IBD):Crohn’s Disease, Ulcerative Colitis
5) By General Gut Health: Immune System Support, Digestive Health, Gut Microbiome Restoration
The key trends in the hospital and nursing home probiotics market are:
•Major advancements in probiotic formulations are being observed.
•Improvements in delivery methods for targeted healthcare settings are becoming increasingly prevalent.
•Innovation in probiotics for infection prevention is a significant emerging trend.
•There is a developing trend for specialized probiotics for elderly and immunocompromised patients and integration of digital solutions.
Major players in the hospital and nursing home probiotics market are:
• Nestlé Health Science
• BASF SE
• Procter & Gamble Company
• Abbott Laboratories
• Lactalis Group
• Danone S.A.
• General Mills Inc.
• Arla Foods Group
• DuPont de Nemours Inc.
• Kerry Group plc
• Koninklijke DSM N.V.
• Glanbia PLC
• Yakult Honsha Co. Ltd.
• Chr. Hansen Holding A/S
• Lallemand Inc.
• BioGaia AB
• Klaire Labs
• SymbioPharm GmbH
• Synlogic Inc.
• Vitakem Nutraceuticals
North America was the largest region in the hospital and nursing home probiotics market in 2024